首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >SURVEY OF PRESCRIPTION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE AND DIABETIC HYPERTENSIVE PATIENTS
【24h】

SURVEY OF PRESCRIPTION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE AND DIABETIC HYPERTENSIVE PATIENTS

机译:高血压和糖尿病高血压患者抗高血压药处方模式调查

获取原文
获取外文期刊封面目录资料

摘要

Objective: This study was conducted in order to establish the drug prescribing trend of anti-hypertensive agents in hypertensives and diabetichypertensives in General Medicine Department of Veer Surendra Sai Medical College and Hospital, Sambalpur, Odisha.Methods: A prospective study of 2 months duration was conducted at the Veer Surendra Sai Medical College and Hospital, Sambalpur. Theprescriptions containing antihypertensives were collected from the patients attending the outpatient department of general medicine. Pregnantwomen were excluded from the study.Results: A total of 422 prescriptions were monitored, of which 285 were male and 137 were female. The age group of the patients varies from 35 to75 years. Among 422 prescriptions, 118 prescriptions were of hypertensives and 304 prescriptions were diabetic hypertensives. Among hypertensives,48% of patients were treated with anti-hypertensive drug combinations and 52% of patients were treated with single anti-hypertensive drug. 83%patients are suffering from primary hypertension (HTN) and only 17% patients suffering from secondary HTN. For the treatment of HTN, bothmonotherapy and combination therapy were followed. In monotherapy, amlodipine was most commonly prescribed followed by telmisartan. Incombination therapy, a two-drug combination consisting of calcium channel blockers (amlodipine) and beta blocker (atenolol) were given to themajority of patients, followed by amlodipine and AT1 antagonist (telmisartan or olmesartan) combination. Among diabetic hypertensives, 31% ofpatients were treated with single anti-hypertensive drug and 69% of patients were treated with anti-hypertensive drug combinations. In monotherapy,beta-blocker (metoprolol) was most commonly prescribed. In combination therapy, a two-drug combination consisting of calcium channel blockers(amlodipine) and beta blocker (atenolol or metoprolol) were given to the majority of patients, followed by a combination of calcium channel blockers(amlodipine) and AT1 antagonist (telmisartan or olmesartan).Conclusion: The present study represents the current prescribing trend for anti-hypertensive agents. According to JNC 7 guidelines, for Stage 1 HTN(systolic blood pressure [SBP] 140-159 or diastolic blood pressure [DBP] 90-99 mmHg), thiazides-type diuretics should be prescribed. For Stage 2HTN (SBP ≥160 or DBP ≥100 mmHg), two drug combinations (usually thiazide-type diuretics and angiotensin converting enzyme inhibitors) shouldbe prescribed. In our study, the prescription pattern does not follow the guideline.
机译:目的:本研究旨在确定奥里萨邦桑巴尔布尔Veer Surendra Sai医学院和医院全科医学部高血压和糖尿病降压药中抗高血压药的处方趋势。方法:前瞻性研究为期2个月,在Sambalpur的Veer Surendra Sai医学院和医院进行。含有降压药的处方是从就诊于普通科门诊的患者中收集的。结果:共监测了422种处方,其中男性285例,女性137例。患者的年龄段为35至75岁。在422份处方中,有118份是高血压处方,有304份是糖尿病高血压处方。在高血压患者中,有48%的患者接受过抗高血压药物组合治疗,有52%的患者接受了单一抗高血压药物治疗。 83%的患者患有原发性高血压(HTN),而只有17%的患者患有继发性HTN。对于HTN的治疗,遵循单一疗法和联合疗法。在单一疗法中,氨氯地平最常开处方,然后是替米沙坦。多数患者接受组合疗法,即由钙通道阻滞剂(氨氯地平)和β阻滞剂(阿替洛尔)组成的两药组合,然后是氨氯地平和AT1拮抗剂(替米沙坦或奥美沙坦)的组合。在糖尿病高血压患者中,有31%的患者接受了单一抗高血压药物的治疗,而69%的患者接受了抗高血压药物的联合治疗。在单一疗法中,最常使用β受体阻滞剂(美托洛尔)。在联合治疗中,大多数患者接受了由钙通道阻滞剂(氨氯地平)和β受体阻滞剂(阿替洛尔或美托洛尔)组成的两药组合,随后是钙通道阻滞剂(氨氯地平)和AT1拮抗剂(替米沙坦或结论:本研究代表了抗高血压药的当前处方趋势。根据JNC 7准则,对于第1阶段HTN(收缩压[SBP] 140-159或舒张压[DBP] 90-99 mmHg),应规定使用噻嗪类利尿剂。对于2HTN期(SBP≥160或DBP≥100mmHg),应开两种药物组合(通常为噻嗪类利尿剂和血管紧张素转化酶抑制剂)。在我们的研究中,处方模式未遵循指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号